The Effectiveness of a Novel NaV1.7 Receptor Inhibitor in Dogs Affected by Chiari-like Malformation and/or Syringomyelia 

Enrollment Status: Currently Enrolling

Inclusion criteria: 

  • Cavalier King Charles Spaniel, 2 to 8 years old 
  • Chiari-like malformation and/or syringomyelia diagnosed by MRI (this can be done as part of their workup)
  • Clinical signs consistent with CM/SM-associated pain
  • Pain medications unchanged for at least 6 weeks before enrollment
  • Normal kidney and liver function on bloodwork (this can be done as part of their workup)
  • Owner willing to give the nasal spray twice a day at home, complete the questionnaires, and attend all study visits 

Exclusion criteria: 

  • Abnormal kidney or liver values on screening bloodwork
  • Any change in pain medication within the previous 6 weeks, or a planned change during the study
  • Nasal or upper respiratory disease that would interfere with nasal dosing
  • Other significant systemic, orthopedic, or neurological disease that could confound pain assessment
  • Pregnant or lactating dogs
  • Temperament that prevents safe handling, nasal dosing, or sensory testing without sedation 

Treatment: At your first visit, your dog will have a full check-up. This includes a physical exam, a nerve and reflex exam, a blood test, and some gentle sensory tests. For those tests we check how your dog reacts to light touch, mild warmth, and a very small electrical tingle on the skin. You’ll also fill out two short questionnaires about your dog’s comfort and daily life.

Your dog will then receive a nasal spray twice daily at home for 4 weeks. A member of our team will give the first dose and show you how to do it. After a 2-week break, your dog gets a second nasal spray for another 4 weeks. One of the two sprays contains the study medication and the other is a placebo, an inactive solution. The order is determined by chance, and neither you nor our team will know which spray your dog gets.

Along the way, you’ll fill out the questionnaires again. Your dog will come back for blood tests and sensory testing at the end of each 4-week period and at the end of the break. Your dog keeps taking their usual pain medications the whole time.

Your dog’s comfort comes first. No sedation or anesthesia is used. The sensory tests stop as soon as your dog notices the sensation, such as with an ear flick or a glance, and are stopped immediately at any sign of discomfort. We’ll watch closely for any side effects. If one occurs, your dog will be taken off the study and referred back to your regular veterinarian. 

Cost: 

Covered by the study: The study medication and nasal spray devices, Blood tests at four points during the study, Neurological exams, Sensory testing

Discounted: If your dog still needs an MRI to confirm the diagnosis, it will be done at UF with a 20% research discount. You pay the remaining cost.

Not covered: Your dog’s regular pain medications, Treatment of any side effects or other health problems that come up during the study, Any other veterinary care not listed above 

Contact information: If you have questions regarding this study or would like see if your dog is a good candidate, please contact Dr. Ludovica Chiavaccini at lchiavaccini@ufl.edu 

PIs: Dr. Ludovica Chiavaccini, lchiavaccini@ufl.edu 

Background information:

Many small dogs—especially Cavalier King Charles Spaniels—are born with a malformation of their skull, called Chiari-like malformation, that can lead to a painful condition called syringomyelia, where fluid builds in the spinal cord. Dogs with this problem can suffer from serious pain and discomfort, including crying out for no clear reason, scratching at their neck without touching it, tiring quickly, being sensitive to collars, showing pain when going to the bathroom, sleeping poorly, and acting anxious or fearful. Right now, the medicines available only manage some of the symptoms and don’t work well for every dog. Our team is testing a new treatment called Compound 194, given as a nasal spray, which is designed to calm down the pain signals in the nervous system without needing to be swallowed or absorbed through the stomach. Early lab work suggests this approach could target the pain pathway involved in this disease. We are now running the first study to see if giving this nasal spray twice a day can meaningfully reduce pain and improve quality of life for these dogs, using feedback directly from their owners to measure how well it works.

IFAS

As part of both the Institute of Food and Agricultural Sciences and the Academic Health Center, Veterinary Medicine is dedicated to advancing animal, human and environmental health through teaching, research, extension and patient care.

[Empty]

Scholars Program

The Boehringer Ingelheim Veterinary Scholars Program offers DVM students an opportunity to gain exposure in biomedical research.

Boehringer Ingelheim Logo

Our Hospitals

Need animal care? Visit the UF Small Animal and Large Animal Hospitals. From dogs, cats, birds and exotics to horses, cattle, llamas, pigs and many other large farm or food animals, our experienced veterinarian staff is ready to assist.

[EMPTY]